Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online program aims to ease burden on lung cancer caregivers

NCT ID NCT06383988

Symptom relief Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times

Summary

This study tests a new web-based tool called CONNECT, designed to help caregivers of people with stage II to IV lung cancer find support resources. About 216 caregivers will use the tool and have sessions with a navigator to see if it helps them feel more supported. The goal is to improve caregivers' well-being and reduce stress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 216 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion Criteria: * Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads * Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer * Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining * Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours * Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate Caregiver Inclusion Criteria: * Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads * Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate * Must have access to the internet at home or be willing to use CONNECT in the clinic * Must have access to telephone to complete sessions with the central caregiver navigator Patient Exclusion Criteria: * Patients who have completed treatment for their lung cancer at the time of study enrollment * Enrolled in hospice care * Unable to read and English and not willing to have someone read surveys for them Caregiver Exclusion Criteria: * Self-report currently receiving cancer treatment * Unable to read and communicate in English, as the CONNECT intervention is currently only available in English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stage II lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung carcinoma lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stage II lung cancer Stage III lung cancer Stage IV lung cancer

Contacts and locations

Locations

  • Augusta University Medical Center

    Augusta, Georgia, 30912, United States

  • Aurora BayCare Medical Center

    Green Bay, Wisconsin, 54311, United States

  • Aurora Cancer Care-Kenosha South

    Kenosha, Wisconsin, 53142, United States

  • Aurora Saint Luke's Medical Center

    Milwaukee, Wisconsin, 53215, United States

  • Beebe Health Campus

    Rehoboth Beach, Delaware, 19971, United States

  • Beebe South Coastal Health Campus

    Millville, Delaware, 19967, United States

  • Community Medical Center

    Scranton, Pennsylvania, 18510, United States

  • CoxHealth South Hospital

    Springfield, Missouri, 65807, United States

  • Geisinger Wyoming Valley/Henry Cancer Center

    Wilkes-Barre, Pennsylvania, 18711, United States

  • Gibbs Cancer Center-Gaffney

    Gaffney, South Carolina, 29341, United States

  • Gibbs Cancer Center-Pelham

    Greer, South Carolina, 29651, United States

  • Hawaii Cancer Care - Westridge

    ‘Aiea, Hawaii, 96701, United States

  • Hawaii Cancer Care Inc - Waterfront Plaza

    Honolulu, Hawaii, 96813, United States

  • Kaiser Permanente - Lone Tree

    Lone Tree, Colorado, 80124, United States

  • Kaiser Permanente - Rock Creek

    Lafayette, Colorado, 80026, United States

  • Kaiser Permanente-Franklin

    Denver, Colorado, 80205, United States

  • Lake Regional Hospital

    Osage Beach, Missouri, 65065, United States

  • MGC Hematology Oncology-Union

    Union, South Carolina, 29379, United States

  • Montefiore Medical Center-Einstein Campus

    The Bronx, New York, 10461, United States

  • Prisma Health Cancer Institute - Butternut

    Greenville, South Carolina, 29605, United States

  • Prisma Health Cancer Institute - Eastside

    Greenville, South Carolina, 29615, United States

  • Spartanburg Medical Center

    Spartanburg, South Carolina, 29303, United States

  • ThedaCare Regional Cancer Center

    Appleton, Wisconsin, 54911, United States

  • ThedaCare Regional Medical Center - Neenah

    Neenah, Wisconsin, 54956, United States

  • Wake Forest NCORP Research Base

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.